Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Experimental Medicine|March 21, 2019
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AMLFaisal Basheer, George Giotopoulos, Eshwar Meduri, et al.
Cancer Cell|February 14, 2018
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic ProgenitorsChristopher A G Booth, Nikolaos Barkas, Wen Hao Neo, et al.
NEJM Evidence|February 6, 2024
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart DiseaseTian X Zhao, Rouchelle S Sriranjan, Zewen Kelvin Tuong, et al.
Nature Communications|May 20, 2025
CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibitionAlicia Garcia-Gimenez, Jonathan E Ditcham, Dhoyazan M A Azazi, et al.
Nature Communications|April 14, 2023
Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell deathKeith Woodley, Laura S Dillingh, George Giotopoulos, et al.
Nature Communications|October 6, 2019
Genetic modification of primary human B cells to model high-grade lymphomaRebecca Caeser, Miriam Di Re, Joanna A Krupka, et al.
Nature Genetics|August 14, 2023
In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesisDavid Lara-Astiaso, Ainhoa Goñi-Salaverri, Julen Mendieta-Esteban, et al.
Pageof 10